Winnoz Technology Inc

Winnoz Technology, Inc. is a company that specializes in developing innovative solutions for decentralized healthcare and biosensing technology. The company's core business focuses on creating point-of-care testing (POCT) technology that enables rapid and convenient testing in various settings, including clinics, pharmacies, homes, and rural areas. Winnoz offers a range of products, including the Haiim vacuum-assisted blood collection device, the eGGi molecular detection system, and the eazyOne molecular detection system. These products utilize technologies such as loop-mediated isothermal amplification (LAMP) and are designed to be customizable, user-friendly, and compatible with commercial testing kits. The company's mission is to decentralize healthcare, improve patient outcomes, and enhance access to screening worldwide by providing innovative testing solutions that overcome traditional healthcare barriers.

Winnoz® is a biotech company focused on the Point of Care Testing platform technology (POCT).

Our vision is to be the family health steward of every customer.

With the POCT platform from blood collection, detection and big data analysis, we enable more contribution for human health management for anyone, anywhere.

We first launched the WinGene genetic testing service by offering risk report with genetic testing to better assist customers in managing health and well-being.

In 2019, our patented technology Haiim®, a unique blood collection device, obtained Taiwan FDA Class I Medical Device and got CE certified in 2020. Now, we collaborate with many worldwide distributors for global expansion and aim for US FDA cleared by 2021.

We also developed eGGi molecular detection system, a compact and robust instrument, which is based on isothermal DNA/RNA amplification method that can be used in airports, sport venues, pharmacies and workplaces.

Haiim® Automatic vacuum assisted fingertip blood micro collection device
eGGi - Molecular Detection System

Biotechnology
Preventive Medicine
Biomarkers
Biosenors
Microfluidics
IVD
Medical Devices
Molecular testing
Disease Risk Assessment

2014